DD

Debaleena Das

Active Director Director DIN 10240798
DIN 10240798 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Debaleena Das

Data last updated:

Debaleena Das is a Director at Taruba Biologicals Private Limited (since 2023). Taruba Biologicals Private Limited reported revenue of ₹1.6 Lakh (FY 2025).

DIN 10240798
Primary Designation Director
First Appointment 17 Jul 2023
Oldest Company Age 3 yrs
Largest company Taruba Biologicals Private Limited · ₹1.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Taruba Biologicals Private Limited U32509WB2023PTC263539
Director17 Jul 20232023₹1.6 Lakh (FY 2025)Active

Board colleagues of Debaleena Das

NameDINCompanyDesignation
Sai Gunaranjan Patanjali10240797Taruba Biologicals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Taruba Biologicals Private Limited
Premium access

Shareholding and investment profile for Debaleena Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Debaleena Das

Debaleena Das currently holds 1 directorship: Taruba Biologicals Private Limited (Director, since 17 Jul 2023, revenue ₹1.6 Lakh (FY 2025)).

Debaleena Das was first appointed on 17 Jul 2023 as Director at Taruba Biologicals Private Limited.

The current boards of Debaleena Das's companies include Sai Gunaranjan Patanjali (Taruba Biologicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available